Effects of a 10 or 15 mg single intravenous bolus of ivabradine versus placebo on heart rate control during a multislice computed tomography coronary angiography for the evaluation of coronary artery disease. A randomised, double-blind, international, multi-centre study.
Phase of Trial: Phase III
Latest Information Update: 23 Mar 2016
At a glance
- Drugs Ivabradine (Primary)
- Indications Coronary artery disease
- Focus Pharmacodynamics
- 24 Mar 2012 This trial is recruiting in United Kingdom, Spain and France.
- 31 May 2010 Status changed from recruiting to completed as reported by ISRCTN: Current Controlled Trials record.
- 13 Dec 2008 New trial record.